Fig. 1From: Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritisTrajectory-based clustering. Trajectory clustered into 4 groups (A) and changes in the disease activities of each individual over 4Â years (B). Abbreviation: DAS28, disease activity scores with 28-joints assessment using the erythrocyte sedimentation rateBack to article page